NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome

Zeuzem S, Mizokami M, Pianko S, Mangia A, Han KH, Martin R, et al. NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome. J Hepatol. 2017;66(5):910-918.

Publication Type:

Journal Article

Source:

J Hepatol, Volume 66, Issue 5, p.910-918 (2017)

Cited On:

External Third-party Web Link:

https://www.ncbi.nlm.nih.gov/pubmed/28108232

Export Citation:

RIS Format

Top